These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34301992)

  • 1. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
    Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
    Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.
    Tan AY; Zhang T; Michaeel A; Blumenfeld J; Liu G; Zhang W; Zhang Z; Zhu Y; Rennert L; Martin C; Xiang J; Salvatore SP; Robinson BD; Kapur S; Donahue S; Bobb WO; Rennert H
    J Am Soc Nephrol; 2018 Aug; 29(8):2139-2156. PubMed ID: 30042192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
    Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
    J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA
    Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
    J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
    Jung HJ; Dixon EE; Coleman R; Watnick T; Reiter JF; Outeda P; Cebotaru V; Woodward OM; Welling PA
    Physiol Genomics; 2023 Nov; 55(11):565-577. PubMed ID: 37720991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative transcriptomics of shear stress treated Pkd1
    Kunnen SJ; Malas TB; Formica C; Leonhard WN; 't Hoen PAC; Peters DJM
    Biomed Pharmacother; 2018 Dec; 108():1123-1134. PubMed ID: 30372813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.
    Leonhard WN; Zandbergen M; Veraar K; van den Berg S; van der Weerd L; Breuning M; de Heer E; Peters DJ
    J Am Soc Nephrol; 2015 Jun; 26(6):1322-33. PubMed ID: 25361818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
    Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
    Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
    Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of PKD1 and PKD2 Somatic Variants in Autosomal Dominant Polycystic Kidney Cyst Epithelial Cells by Whole-Genome Sequencing.
    Zhang Z; Bai H; Blumenfeld J; Ramnauth AB; Barash I; Prince M; Tan AY; Michaeel A; Liu G; Chicos I; Rennert L; Giannakopoulos S; Larbi K; Hughes S; Salvatore SP; Robinson BD; Kapur S; Rennert H
    J Am Soc Nephrol; 2021 Dec; 32(12):3114-3129. PubMed ID: 34716216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease.
    Chang AR; Moore BS; Luo JZ; Sartori G; Fang B; Jacobs S; Abdalla Y; Taher M; Carey DJ; Triffo WJ; Singh G; Mirshahi T
    JAMA; 2022 Dec; 328(24):2412-2421. PubMed ID: 36573973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Mutations in the PKD1 and PKD2 Genes of Chinese Patients with Autosomal Dominant Polycystic Kidney Disease.
    Xu D; Ma Y; Gu X; Bian R; Lu Y; Xing X; Mei C
    Kidney Blood Press Res; 2018; 43(2):297-309. PubMed ID: 29529603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease.
    Choi R; Park HC; Lee K; Lee MG; Kim JW; Ki CS; Hwang YH; Ahn C
    BMC Med Genet; 2014 Dec; 15():129. PubMed ID: 25491204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
    Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
    Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.